1. Home
  2. KRMD vs IVA Comparison

KRMD vs IVA Comparison

Compare KRMD & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$6.54

Market Cap

186.3M

Sector

Health Care

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.44

Market Cap

804.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
IVA
Founded
1980
2011
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
804.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KRMD
IVA
Price
$6.54
$4.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$5.88
$17.14
AVG Volume (30 Days)
215.8K
215.5K
Earning Date
11-12-2025
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
$19,929,536.00
Revenue This Year
$23.36
N/A
Revenue Next Year
$18.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.12
N/A
52 Week Low
$1.86
$2.11
52 Week High
$6.61
$7.98

Technical Indicators

Market Signals
Indicator
KRMD
IVA
Relative Strength Index (RSI) 74.17 51.65
Support Level $5.48 $4.12
Resistance Level $5.88 $4.58
Average True Range (ATR) 0.34 0.22
MACD 0.02 0.02
Stochastic Oscillator 89.42 59.09

Price Performance

Historical Comparison
KRMD
IVA

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: